Chuo-ku, Japan

Yui Yamaura

This inventor holds 1 USPTO granted patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yui Yamaura. Retrieved from https://idiyas.com/inventor/yui-yamaura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yui Yamaura: Innovator in Pharmaceutical Chemistry

Introduction

Yui Yamaura is a notable inventor based in Chuo-ku, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit specific integrin activities.

Latest Patents

Yui Yamaura holds a patent for "Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity." This patent describes a compound that exhibits α4 integrin inhibitory action. The compound is a sulfonamide derivative represented by a specific formula, which includes various substituents as detailed in the patent specification.

Career Highlights

Yui Yamaura is currently employed at Ea Pharma Co., Ltd., where she continues her research and development efforts in pharmaceutical innovations. Her work focuses on creating effective therapeutic agents that can improve patient outcomes.

Collaborations

Yui collaborates with esteemed colleagues, including Munetaka Tokumasu and Masatsugu Noguchi, who contribute to her research endeavors and enhance the innovative environment at her workplace.

Conclusion

Yui Yamaura's contributions to pharmaceutical chemistry and her innovative patent demonstrate her commitment to advancing medical science. Her work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…